Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3
Original Research
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,479 | Dovepress* | 15,955+ | 3,490 | 19,445 | |
| PubMed Central* | 1,524 | 765 | 2,289 | ||
| Totals | 17,479 | 4,255 | 21,734 | ||
|
*Since 25 January 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar